These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
82 related items for PubMed ID: 26278257
1. α-Casein Inhibits Insulin Amyloid Formation by Preventing the Onset of Secondary Nucleation Processes. Librizzi F, Carrotta R, Spigolon D, Bulone D, San Biagio PL. J Phys Chem Lett; 2014 Sep 04; 5(17):3043-8. PubMed ID: 26278257 [Abstract] [Full Text] [Related]
2. α-Casein inhibition mechanism in concanavalin A aggregation process. Carrotta R, Vilasi S, Librizzi F, Martorana V, Bulone D, San Biagio PL. J Phys Chem B; 2012 Dec 20; 116(50):14700-7. PubMed ID: 23171317 [Abstract] [Full Text] [Related]
6. Secondary nucleation and accessible surface in insulin amyloid fibril formation. Foderà V, Librizzi F, Groenning M, van de Weert M, Leone M. J Phys Chem B; 2008 Mar 27; 112(12):3853-8. PubMed ID: 18311965 [Abstract] [Full Text] [Related]
7. Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. Jayamani J, Shanmugam G. Eur J Med Chem; 2014 Oct 06; 85():352-8. PubMed ID: 25105923 [Abstract] [Full Text] [Related]
8. Intramolecular charge interactions as a tool to control the coiled-coil-to-amyloid transformation. Pagel K, Wagner SC, Rezaei Araghi R, von Berlepsch H, Böttcher C, Koksch B. Chemistry; 2008 Oct 06; 14(36):11442-51. PubMed ID: 19016556 [Abstract] [Full Text] [Related]
11. In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-α-peptide architecture. Richman M, Wilk S, Chemerovski M, Wärmländer SK, Wahlström A, Gräslund A, Rahimipour S. J Am Chem Soc; 2013 Mar 06; 135(9):3474-84. PubMed ID: 23360549 [Abstract] [Full Text] [Related]
16. Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties. Malisauskas M, Weise C, Yanamandra K, Wolf-Watz M, Morozova-Roche L. J Mol Biol; 2010 Feb 12; 396(1):60-74. PubMed ID: 19913026 [Abstract] [Full Text] [Related]
17. Investigation of the mechanism of beta-amyloid fibril formation by kinetic and thermodynamic analyses. Lin MS, Chen LY, Tsai HT, Wang SS, Chang Y, Higuchi A, Chen WY. Langmuir; 2008 Jun 03; 24(11):5802-8. PubMed ID: 18452319 [Abstract] [Full Text] [Related]
18. Amyloid fibril formation by bovine milk alpha s2-casein occurs under physiological conditions yet is prevented by its natural counterpart, alpha s1-casein. Thorn DC, Ecroyd H, Sunde M, Poon S, Carver JA. Biochemistry; 2008 Mar 25; 47(12):3926-36. PubMed ID: 18302322 [Abstract] [Full Text] [Related]
19. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro. Ono K, Takasaki J, Takahashi R, Ikeda T, Yamada M. J Neurosci Res; 2013 Oct 25; 91(10):1371-81. PubMed ID: 23913715 [Abstract] [Full Text] [Related]
20. Amyloid fibrils formation and amorphous aggregation in concanavalin A. Vetri V, Canale C, Relini A, Librizzi F, Militello V, Gliozzi A, Leone M. Biophys Chem; 2007 Jan 25; 125(1):184-90. PubMed ID: 16934387 [Abstract] [Full Text] [Related] Page: [Next] [New Search]